Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) EBT Margin (2016 - 2025)

Historic EBT Margin for Silo Pharma (SILO) over the last 11 years, with Q3 2025 value amounting to 6160.54%.

  • Silo Pharma's EBT Margin fell 10076200.0% to 6160.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 7041.12%, marking a year-over-year decrease of 18903100.0%. This contributed to the annual value of 6092.59% for FY2024, which is 10565500.0% down from last year.
  • Silo Pharma's EBT Margin amounted to 6160.54% in Q3 2025, which was down 10076200.0% from 6681.24% recorded in Q2 2025.
  • In the past 5 years, Silo Pharma's EBT Margin ranged from a high of 644539.63% in Q4 2021 and a low of 1344010.56% during Q3 2021
  • For the 5-year period, Silo Pharma's EBT Margin averaged around 41261.74%, with its median value being 5169.37% (2024).
  • In the last 5 years, Silo Pharma's EBT Margin crashed by 2000000000bps in 2021 and then soared by 2000000000bps in 2022.
  • Over the past 5 years, Silo Pharma's EBT Margin (Quarter) stood at 644539.63% in 2021, then plummeted by -101bps to 9224.63% in 2022, then surged by 37bps to 5833.66% in 2023, then tumbled by -65bps to 9600.69% in 2024, then skyrocketed by 36bps to 6160.54% in 2025.
  • Its last three reported values are 6160.54% in Q3 2025, 6681.24% for Q2 2025, and 5721.94% during Q1 2025.